Reaction
Premenstrual Syndrome reporting signals
As of the last recalculation, Premenstrual Syndrome appears in 1,347 FAERS reports alongside 10 co-occurring drug terms. The strongest observed disproportionality signal is DROSPIRENONE AND ETHINYL ESTRADIOL (PRR 38.1).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Drospirenone And Ethinyl Estradiol | 101 | 38.1 | 38.2 |
| Levonorgestrel | 318 | 31.6 | 31.7 |
| Etonogestrel And Ethinyl Estradiol | 43 | 30.9 | 31.0 |
| Standardized Senna Concentrate | 19 | 23.7 | 23.7 |
| Copper | 48 | 17.8 | 17.8 |
| Orlistat | 20 | 12.1 | 12.1 |
| Medroxyprogesterone Acetate | 36 | 11.4 | 11.5 |
| Etonogestrel | 34 | 11.3 | 11.3 |
| Elexacaftor, Tezacaftor, And Ivacaftor | 8 | 10.0 | 10.0 |
| Galcanezumab-Gnlm | 4 | 2.0 | 2.0 |